Item 7.01 Regulation FD Disclosure.
John P. Butler, President and Chief Executive Officer of Akebia Therapeutics,
Inc. (the "Company"), plans to virtually present the information in the J.P.
Morgan Healthcare Conference Presentation attached hereto as Exhibit 99.1 (the
"Presentation") at the 39th Annual J.P. Morgan Healthcare Conference on
January 13, 2021 at 2:50 p.m., Eastern Time. Spokespersons of the Company also
plan to present the information in the Presentation at various meetings
beginning on January 12, 2021, including investor and analyst meetings.
The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit
99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities under that Section. The information contained in this
Item 7.01 and Exhibit 99.1 hereto shall not be incorporated by reference into
any filing with the U.S. Securities and Exchange Commission (the "SEC") made by
the Company under the Securities Act of 1933, as amended, or the Exchange Act,
whether made before or after the date hereof, regardless of any general
incorporation language in such filing.
By providing the information in Item 7.01 of this Current Report on
Form 8-K, including Exhibit 99.1 hereto, the Company is not making an admission
as to the materiality of any information herein. The information contained in
this Current Report on Form 8-K is intended to be considered in the context of
more complete information included in the Company's filings with the SEC and
other public announcements that the Company has made and may make from time to
time by press release or otherwise. The Company undertakes no duty or obligation
to update or revise the information contained in this Current Report on
Form 8-K, although it may do so from time to time as its management believes is
appropriate. Any such updating may be made through the filing of other reports
or documents with the SEC, through press releases or through other public
disclosures.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Exhibit Description
99.1 J.P. Morgan Healthcare Conference Presentation
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses